| 000 | 01812 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514222011.0 | ||
| 264 | 0 | _c20050617 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a1526-5900 | ||
| 024 | 7 |
_a10.1016/j.jpain.2004.12.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaulson, Daniel M | |
| 245 | 0 | 0 |
_aAlvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial. _h[electronic resource] |
| 260 |
_bThe journal of pain _cMar 2005 |
||
| 300 |
_a184-92 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAnalgesics, Opioid _xadverse effects |
| 650 | 0 | 4 |
_aCathartics _xadministration & dosage |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 |
_aConstipation _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGastrointestinal Motility _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
| 650 | 0 | 4 |
_aReceptors, Opioid, mu _xantagonists & inhibitors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aKennedy, Daniel T | |
| 700 | 1 | _aDonovick, Roger A | |
| 700 | 1 | _aCarpenter, Randall L | |
| 700 | 1 | _aCherubini, Maryann | |
| 700 | 1 | _aTechner, Lee | |
| 700 | 1 | _aDu, Wei | |
| 700 | 1 | _aMa, Yuju | |
| 700 | 1 | _aSchmidt, William K | |
| 700 | 1 | _aWallin, Bruce | |
| 700 | 1 | _aJackson, David | |
| 773 | 0 |
_tThe journal of pain _gvol. 6 _gno. 3 _gp. 184-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpain.2004.12.001 _zAvailable from publisher's website |
| 999 |
_c15445205 _d15445205 |
||